Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT

SIMPLE SUMMARY: Despite the complete treatment with surgery, chemotherapy and radiotherapy, patients with glioblastoma have a devasting prognosis. Although the role of extending temozolomide treatment has been explored, the results are inconclusive. Recent evidence suggested that tumor vascularity m...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez-Torres, María del Mar, Fuster-García, Elies, Balaña, Carmen, Puig, Josep, García-Gómez, Juan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582449/
https://www.ncbi.nlm.nih.gov/pubmed/34771583
http://dx.doi.org/10.3390/cancers13215420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582449/
https://www.ncbi.nlm.nih.gov/pubmed/34771583
http://dx.doi.org/10.3390/cancers13215420

Ejemplares similares